Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Geneva, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
Addex Therapeutics Ltd. has filed 274 SEC EDGAR filings since 24 Sep 2019

SEC filing history

Showing 151-175 of 274 matching filings.

Per page
25
Current page
7
6-K File 001-39179

FORM 6-K

Filing date
15 Aug 2022
Reporting date
15 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91805

SC 13D/A

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-454872

D filing

Filing date
04 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
26 Jul 2022
Reporting date
26 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-255089

424B5

Filing date
26 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
22 Jul 2022
Reporting date
22 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
21 Jul 2022
Reporting date
21 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
21 Jul 2022
Reporting date
21 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-262050

424B5

Filing date
20 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
17 Jun 2022
Reporting date
17 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
27 May 2022
Reporting date
27 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
10 May 2022
Reporting date
10 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
05 May 2022
Reporting date
05 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-235554

EFFECT filing

Filing date
19 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
13 Apr 2022
Reporting date
13 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
06 Apr 2022
Reporting date
06 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262050

EFFECT filing

Filing date
04 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-262050

POS AM

Filing date
31 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
31 Mar 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-235554

POS AM

Filing date
29 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
10 Mar 2022
Reporting date
10 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91805

SC 13G/A - AMENDMENT NO. 2

Filing date
18 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91805

SC 13G

Filing date
15 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .